Univariate analyses of demographic and clinical data in patients with or without postoperative deterioration of performance status and cardiopulmonary complications
| Deterioration of performance status | OR (95% CI) | p-value | Cardiopulmonary complications | OR (95% CI) | p-value | |||
| Yes | No | Yes | No | |||||
| Subjects | 26 | 162 | 36 | 152 | ||||
| Age ≥70 years | 16 (61.5) | 88 (54.3) | 1.34 (0.57–3.14) | 0.49 | 23 (63.9) | 81 (53.3) | 1.55 (0.73–3.29) | 0.25 |
| Females | 14 (53.8) | 58 (35.8) | 2.08 (0.91–4.76) | 0.083 | 12 (33.3) | 60 (39.5) | 0.77 (0.36–1.64) | 0.50 |
| Body mass index <18.5 kg·m−2 | 4 (15.4) | 16 (9.9) | 1.66 (0.51–5.42) | 0.40 | 8 (22.2) | 12 (7.9) | 3.33 (1.25–8.9) | 0.016 |
| Comorbidities | 22 (84.6) | 127 (78.4) | 1.52 (0.49–4.69) | 0.47 | 31 (86.1) | 118 (77.6) | 1.79 (0.65–4.95) | 0.26 |
| COPD | 10 (38.5) | 56 (34.6) | 1.16 (0.49–2.73) | 0.73 | 24 (66.7) | 42 (27.6) | 5.14 (2.36–11.2) | <0.001 |
| Charlson comorbidity index score ≥2 | 9 (34.6) | 49 (30.2) | 1.29 (0.54–3.13) | 0.56 | 10 (27.8) | 48 (31.6) | 0.83 (0.37–1.85) | 0.64 |
| ASA classification ≥3 | 14 (53.8) | 60 (37.0) | 1.98 (0.86–4.57) | 0.11 | 19 (52.8) | 55 (36.2) | 1.97 (0.94–4.10) | 0.07 |
| mMRC dyspnoea scale grade ≥II | 5 (19.2) | 28 (17.3) | 1.18 (0.41–3.40) | 0.76 | 7 (19.4) | 26 (17.1) | 1.14 (0.45–2.89) | 0.78 |
| ECOG performance status ≥1 | 7 (26.9) | 31 (19.1) | 1.64 (0.63–4.27) | 0.31 | 10 (27.8) | 28 (18.4) | 1.69 (0.73–3.91) | 0.219 |
Data are presented as n or n (%), unless otherwise stated. COPD: chronic obstructive pulmonary disease; ASA: American Society of Anesthesiologists; mMRC: modified Medical Research Council; ECOG: Eastern Cooperative Oncology Group.